Peripheral Arterial Disease Global Market Analysis, Trends, Growth, Research And Forecast 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Peripheral Arterial Disease Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $6.05 billion In 2028 At A CAGR Of 8.5% :

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4 billion in 2023 to $4.36 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, digital health and remote monitoring.

The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to $6.05 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to interdisciplinary care teams, minimally invasive interventions, lifestyle and exercise prescriptions. Major trends in the forecast period include vascular tele-rehabilitation, multimodal pain management, wound care advances, public health campaigns.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

Peripheral Arterial Disease Market Major Segments
The peripheral arterial disease market covered in this report is segmented -

1) By Treatment Type: Devices; Catheters; Drugs; Other Types
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By End User: Hospitals; Specialty Clinics; Others End-Users

Key Driver - Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market

The rising prevalence of cardiac diseases is driving the growth of the peripheral arterial disease market going forward. Cardiac disease is a typical heart disease that impacts the main blood vessels supplying the heart muscle. Peripheral arterial disease treatment helps cardiac patients with improved blood flow, cardiovascular risk reduction, symptom relief and enhanced quality of life. For instance, in June 2023, according to the Center for Disease Control and Prevention, a US-based government agency, the number of deaths due to cardiovascular diseases reached 695,547 in 2021. Additionally, in April 2022, according to the American College of Cardiology, a US-based non-profit medical association, the risk factors for ischemic heart disease are predicted to increase by 30.7% to 29 million by 2025. Therefore, the rising prevalence of cardiac diseases drives the peripheral arterial disease market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12999&type=smp

Prominent Trend - Innovative Drug Development Initiatives Driving Advancements In The Peripheral Arterial Disease Market

Major companies operating in the peripheral arterial disease market are focused on developing innovative drugs and solutions to sustain their position in the market. Drug development can lead to the development of more effective treatments for PAD, reducing the risk of complications and improving patient outcomes. For instance, in August 2021, The Janssen Pharmaceutical Companies, a Belgium-based pharmaceutical company, received approval for an expanded peripheral artery disease (PAD) indication for the XARELTO (rivaroxaban) dose by the Food and Drug Administration (FDA), a US-based government agency. XARELTO is the first and only therapy for both coronary artery disease (CAD) and PAD, including PAD patients post-LER. This is also recommended for patients with acute limb ischemia and amputation, ischemic stroke and myocardial infarction.

Peripheral Arterial Disease Market Players
Major players in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the peripheral artery disease market in 2023. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Peripheral Arterial Disease Market Report Structure
3. Peripheral Arterial Disease Market Trends And Strategies
4. Peripheral Arterial Disease Market - Macro Economic Scenario
5. Peripheral Arterial Disease Market Size And Growth
…..
27. Peripheral Arterial Disease Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.